The quantitative relationship between deleted mitochondrial DNA and the clinical course of patients with Kearns-Sayre syndrome is poorly understood. We investigated this point using tissue samples obtained at age 10 years when the patient was diagnosed as Kearns-Sayre syndrome and at age 20 years when he died of disseminated intravascular coagulation. By long polymerase chain reaction, a shortened mitochondrial genome (8.8 kb; normal, 16.6 kb) was detected in the patient. By quantitative competitive polymerase chain reaction, the percentage of deletion-carrying mitochondrial DNA was not increased as expected and did not differ significantly by tissue type or sampling time or correlate with clinical course. Although we could not demonstrate that the amounts of wild-type mitochondrial DNA decreased with accelerating progression, it was emphasized that such a reduction of mitochondrial DNA in various tissues, including those of the central nervous system, could play a significant pathogenetic role, since only wild-type mitochondrial DNA is functional in patients with large-scale deletions of mitochondrial DNA. (J Child Neurol 2000;15:750-755).
Get full access to this article
View all access options for this article.
References
1.
Kearns TP, Sayre GP: Retinitis pigmentosa, external ophthalmoplegia, and complete heart block: Unusual syndrome with histologic study in one of two cases. Arch Ophthalmol1958;60:280-289.
2.
Goto Y., Koga Y., Horai S., Nonaka I.: Chronic progressive external ophthalmoplegia: A correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies . J Neurol Sci1990;100:63-69.
3.
Zeviani M., Moraes CT, DiMauro S., et al: Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology1988;38:1339-1346.
4.
Moraes CT, DiMauro S., Zeviani M., et al: Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med1989 ;320:1293-1299.
5.
Shanske S., Moraes Ct, Lombes A., et al: Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology1990;40:24-28.
6.
Larsson NG, Holme E., Kristiansson B., et al: Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res1990 ;28:131-136.
7.
Poulton J., Deadman ME, Bindoff L., et al: Families of mtDNA rearrangements can be detected in patients with mtDNA deletions: Duplications may be a transient intermediate form. Hum Mol Genet1993;2:23-30.
8.
Poulton J., Morten KJ, Weber K., et al: Are duplications of mitochondrial DNA characteristic of Kearns-Sayre syndrome?Hum Mol Genet1994;3:947-951.
9.
Mohri I., Taniike M., Fujimura H., et al: A case of Kearns-Sayre syndrome showing a constant proportion of deleted mitochondrial DNA in blood cells during 6 years of follow-up. J Neurol Sci1998;158:106-109.
10.
Goto Y-I., Itami N., Kajii N., et al: Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. J Pediatr1990 ;116:904-910.
11.
Nakagawa E. , Osari S., Yamanouchi H., et al: Long-term therapy with cytochrome c, flavin mononucleotide and thiamine diphosphate for a patient with Kearns-Sayre syndrome. Brain Dev1996 ; 18:68-70.
12.
De Coo IF, Gussinklo T., Arts PJ, et al: A PCR test for progressive external ophthalmoplegia and Kearns-Sayre syndrome on DNA from blood samples. J Neurol Sci1997;149:37-40.
13.
Anderson S. , Bankier AT, Barrell BG, et al: Sequence and organization of the human mitochondrial genome. Nature1981;290:457-465.
14.
Crisi G., Ferrari G., Merelli E., Cocconcelli P.: MRI in a case of Kearns-Sayre syndrome confirmed by molecular analysis . Neuroradiology1994; 36:37-38.
15.
Kapeller P. , Fazekas F., Offenbacher H., et al: Magnetic resonance imaging and spectroscopy of progressive cerebral involvement in Kearns Sayre syndrome. J Neurol Sci1996;135:126-130.
16.
Hayashi J-I. , Ohta S., Kikuchi A., et al: Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA1991;88:10614-10618.
17.
Moraes CT, Sciacco M., Ricci E., et al: Phenotype-genotype correlations in skeletal muscle of patients with mtDNA deletions. Muscle Nerve1995; Suppl 3:S150-S153.
18.
Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA: A new mitochondrial disease associated with mitochondrial DNA heteroplasmy . Am J Hum Genet1990;46:428-433.
19.
Tatuch Y., Christodoulou J., Feigenbaum A., et al: Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet1992;50:852-858.
20.
Tatuch Y., Pagon RAVlcek B., et al: The 8993 mtDNA mutation: Heteroplasmy and clinical presentation in three families. Eur J Hum Genet1994;2:35-113.
21.
Mita S., Rizzuto R., Moraes CT, et al: Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res1990;18:561-567.
22.
Schon EA, Rizzuto R., Moraes Ct, et al: A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science1989;244: 346-349.
23.
Blok RB, Thorburn DR, Thompson GN, Dahl HH: A topoisomerase II cleavage site is associated with a novel mitochondrial DNA deletion. Hum Genet1995;95:75-81.
24.
Wang J., Wilhelmsson H., Graff C., et al: Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression . Nat Genet1999;21:133-137.
25.
Larsson NG, Wang J., Wilhelmsson H., et al: Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet1999;18:231-236.
26.
Poulton J., Deadman ME, Gardiner RM: Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet1989;1:236-240.
27.
Poulton J., Deadman ME, Gardiner RM: Tandem direct duplications of mitochondrial DNA in mitochondrial myopathy: Analysis of nucleotide sequence and tissue distribution. Nucleic Acids Res1989;17: 10223-10229.
28.
Poulton J., Morten Kj, Marchington D., et al: Duplications of mitochondrial DNA in Kearns-Sayre syndrome. Muscle Nerve1995;Suppl 3:S154-S158.
29.
Fromenty B. , Carrozzo R., Shanske S., Schon EA: High proportions of mtDNA duplications in patients with Kearns-Sayre syndrome occur in the heart. Am J Med Genet1997;71:443-452.
